New Methods Of Treatment Of Ovarian Cancer

New Methods Of Treatment Of Ovarian Cancer.
Women with advanced ovarian cancer who let in fanatical chemotherapy straight away into their stomach area may live at least one year longer than women who inherit standard intravenous chemotherapy, a redone study says. But this survival edge may come at the destruction of more side effects. "The long-term benefits are tuneful significant," said study author Dr Devansu Tewari, commander of gynecologic oncology at the Southern California Permanente Medical Group, in Orange County powder. "There is no look of ovarian cancer treatments that has shown a greater survival advantage".

Intraperitoneal chemotherapy involves bathing the abdominal precinct with chemotherapy agents. By contrast, intravenous (IV) chemotherapy is delivered throughout the body via the bloodstream. The US National Cancer Institute currently recommends intraperitoneal remedy for women with ovarian cancer who have had prominent surgery to exterminate the tumor.

The 10-year backup material from two studies of nearly 900 women with advanced ovarian cancer will be presented Saturday at the annual tryst of the Society of Gynecologic Oncology, in Los Angeles. In 2013, more than 22000 American women will be diagnosed with ovarian cancer, and more than 14000 will be no more from the disease, according to the US National Cancer Institute. There are no primeval screening tests for ovarian cancer, which is why it is often diagnosed when the cancer has already breadth demeanour of the ovaries.

For this reason, survival rates take care of to be very low. In the inexperienced study, women who received the intraperitoneal care were 17 percent more right to survive longer than those who got IV chemotherapy. On average, women in the intraperitoneal rank survived for more than five years, while those who received IV chemotherapy survived for about four years, the learning found. But survival benefits aside, intraperitoneal chemotherapy does converse a greater gamble of side chattels - such as abdominal pain and numbness in the hands and feet - and not all women can admit this high concentration of cancer-killing drugs.

The drugs are also occupied more slowly, providing more exposure to the medicine. The same properties that induce the intraperitoneal therapy more effective likely pit oneself against a role in causing more side effects, the researchers said. In general, six cycles of intraperitoneal chemotherapy are recommended, and can be given in inpatient or outpatient settings. The more cycles the women completed, the greater their survival advantage, the meditate on showed.